Recent Updates
  • Seattle Genetics update
    13 days ago

    Seattle Genetics Announces FDA Regular Approval of ADCETRIS® (Brentuximab Vedotin) for Classical Hodgkin Lymphoma Patients at High Risk of Relapse or Progression as Post-Autologous Hematopoietic Stem Cell Transplantation Consolidation http://glassdoor.com/slink.htm?key=vITYc

  • Seattle Genetics update
    30+ days ago

    Seattle Genetics Reports Second Quarter 2015 Financial Results Total Second Quarter 2015 Revenues of $77.1 Million, Including Record $55.1 Million in ADCETRIS® (Brentuximab Vedotin) U.S. and Canada Net Sales http://glassdoor.com/slink.htm?key=vIKrx

0

Seattle Genetics Video

Provided by employer [?]

Loading...

Seattle Genetics – Why Work For Us?

Advancing Breakthrough Therapies for Cancer

Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. ADCs are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity.

First in a New Class of ADCs

The company’s first ADC product ADCETRIS® (brentuximab vedotin) is approved for two indications in more than 55 countries, including the U.S., Canada, Japan and members of the European Union. The approval of ADCETRIS makes it the first in a new class of ADCs.

To expand on the ADCETRIS opportunity, we are conducting a broad clinical development program to evaluate its therapeutic potential in earlier lines of its approved indications as well as in a range of other lymphoma and non-lymphoma settings.

Seattle Genetics is jointly developing ADCETRIS in collaboration with Takeda Pharmaceutical Company. Under the collaboration, Seattle Genetics has full commercialization rights to ADCETRIS in the United States and Canada. Takeda has exclusive rights to commercialize the product candidate in all other countries.

Advancing Our Robust Pipeline

In addition to ADCETRIS, we are advancing a robust ADC product pipeline designed to address the unmet medical needs of people with cancer. Our strong research and development capabilities are our engine for innovation and long-term growth. Seattle Genetics’ ADC technology is also employed by collaborators and, across both internal and collaborator programs, there are more than 25 ADCs in clinical development using our proprietary approach to empowering antibodies.

Seattle Genetics was founded in 1998 and is headquartered in Bothell, Washington, a suburb of Seattle. The company completed an initial public offering in March 2001, and is traded on the Nasdaq Stock Market under the symbol SGEN. We have more than 650 employees throughout the United States, all with a passion for helping people living with cancer.

Improving the lives of people with cancer through innovative and empowered antibody-based therapies.

We have built a strong corporate culture around the values of integrity, scientific excellence, teamwork, innovation and mutual respect. Seattle Genetics embodies an entrepreneurial spirit that advances breakthrough therapies, which is why we are an acknowledged leader today in antibody-drug conjugate technology.

Values

Passion for helping patients
Revolutionizing therapy for people living with cancer

Integrity
Honesty, respect and trust guide us

Scientific excellence
Premier science empowers our passion

Teamwork & mutual respect
Shared dedication drives successful collaborations

Innovation
Entrepreneurial spirit advances breakthrough therapies

Great work environment
Commitment and opportunity inspire purposeful contribution

We value integrity, scientific excellence, teamwork, innovation and mutual respect

At Seattle Genetics, we are passionate about positively impacting the lives of people with cancer. Team members bring that enthusiasm to everything we do, striving to attain individual goals while recognizing the power of working collaboratively to realize Seattle Genetics' vision of improving patient outcomes. Put your passion to work at Seattle Genetics.

As a company leading the field in developing antibody-drug conjugates, Seattle Genetics fosters an environment that recognizes the challenges of breaking new ground by creating opportunities for focused intellectual curiosity and professional growth. Our state-of-the art facility gives our team members the resources to succeed. Located in Bothell's Canyon Park area, Seattle Genetics is close to major highways, dining and shopping.

Seattle Genetics provides a competitive compensation and benefits package (including stock options, medical, dental, vision, life and disability insurance, employee stock purchase plan and 401(k) plan).

If you are passionate about bringing the best of yourself to everything you do, Seattle Genetics offers challenges, opportunities and rewards. We want to hear from you!

Living in the Pacific Northwest

With ready access to Puget Sound, lakes and mountains, residents of the Seattle area enjoy skiing, hiking, boating and a world-class trail system for bicycling, running or walking. A robust and diverse cultural scene includes multiple theater, music, dance, art and sports venues, providing access to the best of local, national and international talent. The Pacific Northwest is rich in scientific research and discovery, and home to leading academic and research institutions, including the University of Washington and Fred Hutchinson Cancer Research Center. Proximity to Vancouver, B.C., the San Juan Islands, Portland, Oregon and the Olympic and Cascade Mountains makes it easy to play as hard as you work. At Seattle Genetics, you’ll find a rewarding career in a place you will be proud to call home.

Seattle Genetics Reviews

2.9
Rating Trends
Recommend to a friend
Approve of CEO
Seattle Genetics President and CEO Clay B. Siegall
Clay B. Siegall
14 Ratings
  • Helpful (2)

    Some very difficult personalities

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Employee - Senior Clinical Data Manager in Bothell, WA
    Former Employee - Senior Clinical Data Manager in Bothell, WA
    No opinion of CEO

    I worked at Seattle Genetics (More than 3 years)

    Pros

    Huge staff with many opportunities for advancement within the company if your manager is amenable to promoting from within. Good environment for learning the industry.

    Cons

    Located in Bothell, not Seattle. Few/poor transit options so driving was a necessity. Management was very insular and protective of their own, regardless of bad behavior and excessive employee turnover.


Seattle Genetics Interviews

Interview Experience

Interview Experience

55%
11%
33%

Getting an Interview

Getting an Interview

55%
22%
11%
11

Interview Difficulty

3.0
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Scientist Interview

    Anonymous Employee in Seattle, WA
    Declined Offer
    Neutral Experience
    Average Interview

    Application

    I applied online. The process took 2+ months. I interviewed at Seattle Genetics (Seattle, WA) in June 2015.

    Interview

    I applied online, Brief (30 min) phone call with HR recruiter, in person 2-3 hour interview followed by a full day interview where I gave a presentation and I met with multiple people in the department. The HR recruiter explained the job a differently from what the hiring manager described it- it was not a good fit

    Interview Questions

Seattle Genetics Awards & Accolades

Something missing? Add an award
Technology Fast 500 , Deloitte, 2014
Technology Fast 500 , Deloitte, 2013
Most Innovative Growth Companies (6) , Forbes, 2011
BizCycle Certified Workplace (Silver) , Cascade Bicycle Club, 2015
Leaders in Health Care (Innovation in Biopharmaceuticals) , Seattle Business, 2012
Show More

Additional Info

Website www.seattlegenetics.com
Headquarters Bothell, WA
Size 500 to 999 Employees
Founded 1998
Type Company - Public (SGEN)
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (USD) per year

Seattle Genetics is a biotechnology company leading the field of antibody-drug conjugates (ADCs) for the treatment of cancer. Our technology is designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Our lead program, ADCETRIS® (brentuximab vedotin), is the first in a new class of ADCs and, in collaboration ... More

Mission: Improving the lives of people with cancer through innovative and empowered antibody based therapies.

Work at Seattle Genetics? Share Your Experiences

Seattle Genetics

 
Click to Rate
or